Therapeutic Area | MeSH |
---|---|
nervous system diseases | D009422 |
nutritional and metabolic diseases | D009750 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
EXSERVAN | Aquestive Therapeutics | N-212640 RX | 2019-11-22 | 1 products, RLD, RS |
RILUTEK | Covis Pharma | N-020599 RX | 1995-12-12 | 1 products, RLD, RS |
TIGLUTIK KIT | Italfarmaco | N-209080 RX | 2018-09-05 | 1 products, RLD, RS |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
amyotrophic lateral sclerosis | EFO_0000253 | D000690 | G12.21 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Amyotrophic lateral sclerosis | D000690 | HP_0007354 | G12.21 | 4 | 25 | 9 | 2 | 4 | 36 |
Inflammation | D007249 | MP_0001845 | — | — | — | — | 1 | — | 1 |
Fatigue | D005221 | HP_0012378 | R53.83 | — | — | — | 1 | — | 1 |
Tourette syndrome | D005879 | EFO_0004895 | F95.2 | — | — | — | 1 | — | 1 |
Fragile x syndrome | D005600 | — | Q99.2 | — | — | — | 1 | — | 1 |
Memory disorders | D008569 | — | — | — | — | — | 1 | — | 1 |
Affect | D000339 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Spinal cord injuries | D013119 | EFO_1001919 | — | — | 2 | 1 | — | 1 | 3 |
Cerebellar ataxia | D002524 | HP_0001251 | — | — | 2 | 1 | — | — | 2 |
Spinocerebellar ataxias | D020754 | HP_0007263 | — | — | — | 1 | — | — | 1 |
Neuromuscular diseases | D009468 | EFO_1001902 | G70.9 | — | 1 | 1 | — | — | 1 |
Social phobia | D000072861 | EFO_1001917 | F40.1 | — | 1 | 1 | — | — | 1 |
Performance anxiety | D060805 | — | — | — | 1 | 1 | — | — | 1 |
Huntington disease | D006816 | Orphanet_399 | G10 | — | — | 1 | — | — | 1 |
Multiple system atrophy | D019578 | — | — | — | — | 1 | — | — | 1 |
Progressive supranuclear palsy | D013494 | EFO_0002512 | G23.1 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Autism spectrum disorder | D000067877 | HP_0000729 | F84.0 | 1 | 2 | — | — | 1 | 4 |
Bipolar disorder | D001714 | EFO_0000289 | F30.9 | — | 3 | — | — | 1 | 4 |
Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | 3 | 1 | — | — | — | 3 |
Melanoma | D008545 | — | — | 2 | 1 | — | — | — | 3 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | 2 | — | — | — | 2 |
Depression | D003863 | — | F33.9 | — | 2 | — | — | — | 2 |
Obsessive-compulsive disorder | D009771 | EFO_0004242 | F42 | — | 2 | — | — | — | 2 |
Parkinson disease | D010300 | EFO_0002508 | G20 | — | 1 | — | — | — | 1 |
Chronic progressive multiple sclerosis | D020528 | EFO_0003840 | — | — | 1 | — | — | — | 1 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colorectal neoplasms | D015179 | — | — | 1 | — | — | — | — | 1 |
Therapeutic equivalency | D013810 | — | — | 1 | — | — | — | — | 1 |
Neoplasms | D009369 | — | C80 | 1 | — | — | — | — | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | — | — | — | — | 1 |
Treatment-resistant schizophrenia | D000090663 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Schizophrenia | D012559 | EFO_0000692 | F20 | — | — | — | — | 1 | 1 |
Drug common name | Riluzole |
INN | riluzole |
Description | Riluzole is a member of benzothiazoles. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | Nc1nc2ccc(OC(F)(F)F)cc2s1 |
PDB | — |
CAS-ID | 1744-22-5 |
RxCUI | — |
ChEMBL ID | CHEMBL744 |
ChEBI ID | 8863 |
PubChem CID | 5070 |
DrugBank | DB00740 |
UNII ID | 7LJ087RS6F (ChemIDplus, GSRS) |